drugset / Trial / NCT05124457

DETERMINE: Detemir vs NPH

NCT05124457

Phase 2 Recruiting 336 enrolled University of California, Los Angeles
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to compare rates of neonatal hypoglycemia with maternal NPH vs determir use.

Timeline

Start
2022-02-01
Primary completion
2025-06
Completion
2025-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator insulin NPH Protein / enzyme biologic
Subject insulin detemir Protein / enzyme biologic